YESHWANT KRISHNA sold 1.8% of their position (78.22K shares) of VERVE THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.66M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−28.65K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−9.35K
Price / share
$34.78
Trade value
$325.15K
% of position
Common Stock
Shares
−10.37K
Price / share
$36.28
Trade value
$376.28K
% of position
Common Stock
Shares
−8.93K
Price / share
$36.77
Trade value
$328.40K
% of position
Common Stock
Shares
−49.57K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−22.28K
Price / share
$32.32
Trade value
$719.96K
% of position
Common Stock
Shares
−25.53K
Price / share
$33.14
Trade value
$846.16K
% of position
Common Stock
Shares
−1.75K
Price / share
$33.84
Trade value
$59.38K
% of position
Net shares
−156.44K
Net value
-$2.66M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/2/2022 | J · J | −28.65K | — | — | 0.5% | 6.24M | 6.21M |
| Common Stock Indirect | 11/2/2022 | S · Sale | −9.35K | $34.78 | $325.15K | 0.2% | 4.39M | 4.38M |
| Common Stock Indirect | 11/2/2022 | S · Sale | −10.37K | $36.28 | $376.28K | 0.2% | 4.38M | 4.37M |
| Common Stock Indirect | 11/2/2022 | S · Sale | −8.93K | $36.77 | $328.40K | 0.2% | 4.37M | 4.36M |
| Common Stock Indirect | 11/3/2022 | J · J | −49.57K | — | — | 0.8% | 6.21M | 6.16M |
| Common Stock Indirect | 11/3/2022 | S · Sale | −22.28K | $32.32 | $719.96K | 0.5% | 4.36M | 4.34M |
| Common Stock Indirect | 11/3/2022 | S · Sale | −25.53K | $33.14 | $846.16K | 0.6% | 4.34M | 4.31M |
| Common Stock Indirect | 11/3/2022 | S · Sale | −1.75K | $33.84 | $59.38K | 0.0% | 4.31M | 4.31M |
| Total | −156.44K | -$2.66M | ||||||